Adipocyte death, adipose tissue remodeling, and obesity complications. 2007

Katherine J Strissel, and Zlatina Stancheva, and Hideaki Miyoshi, and James W Perfield, and Jason DeFuria, and Zoe Jick, and Andrew S Greenberg, and Martin S Obin
Obesity and Metabolism Laboratory, Jean Mayer-U.S. Department of Agriculture Human Nutrition Research Center on Aging (JM-USDA HNRCA) at Tufts University, Boston, MA, USA.

OBJECTIVE We sought to determine the role of adipocyte death in obesity-induced adipose tissue (AT) inflammation and obesity complications. METHODS Male C57BL/6 mice were fed a high-fat diet for 20 weeks to induce obesity. Every 4 weeks, insulin resistance was assessed by intraperitoneal insulin tolerance tests, and epididymal (eAT) and inguinal subcutaneous AT (iAT) and livers were harvested for histological, immunohistochemical, and gene expression analyses. RESULTS Frequency of adipocyte death in eAT increased from <0.1% at baseline to 16% at week 12, coincident with increases in 1) depot weight; 2) AT macrophages (ATM Phi s) expressing F4/80 and CD11c; 3) mRNA for tumor necrosis factor (TNF)-alpha, monocyte chemotactic protein (MCP)-1, and interleukin (IL)-10; and 4) insulin resistance. ATM Phi s in crown-like structures surrounding dead adipocytes expressed TNF-alpha and IL-6 proteins. Adipocyte number began to decline at week 12. At week 16, adipocyte death reached approximately 80%, coincident with maximal expression of CD11c and inflammatory genes, loss (40%) of eAT mass, widespread collagen deposition, and accelerated hepatic macrosteatosis. By week 20, adipocyte number was restored with small adipocytes, coincident with reduced adipocyte death (fourfold), CD11c and MCP-1 gene expression (twofold), and insulin resistance (35%). eAT weight did not increase at week 20 and was inversely correlated with liver weight after week 12 (r = -0. 85, P < 0.001). In iAT, adipocyte death was first detected at week 12 and remained <or=3%. CONCLUSIONS These results implicate depot-selective adipocyte death and M Phi-mediated AT remodeling in inflammatory and metabolic complications of murine obesity.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000273 Adipose Tissue Specialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white. Fatty Tissue,Body Fat,Fat Pad,Fat Pads,Pad, Fat,Pads, Fat,Tissue, Adipose,Tissue, Fatty
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016923 Cell Death The termination of the cell's ability to carry out vital functions such as metabolism, growth, reproduction, responsiveness, and adaptability. Death, Cell
D017667 Adipocytes Cells in the body that store FATS, usually in the form of TRIGLYCERIDES. WHITE ADIPOCYTES are the predominant type and found mostly in the abdominal cavity and subcutaneous tissue. BROWN ADIPOCYTES are thermogenic cells that can be found in newborns of some species and hibernating mammals. Fat Cells,Lipocytes,Adipocyte,Cell, Fat,Cells, Fat,Fat Cell,Lipocyte

Related Publications

Katherine J Strissel, and Zlatina Stancheva, and Hideaki Miyoshi, and James W Perfield, and Jason DeFuria, and Zoe Jick, and Andrew S Greenberg, and Martin S Obin
April 2012, Adipocyte,
Katherine J Strissel, and Zlatina Stancheva, and Hideaki Miyoshi, and James W Perfield, and Jason DeFuria, and Zoe Jick, and Andrew S Greenberg, and Martin S Obin
December 2009, Journal of cutaneous pathology,
Katherine J Strissel, and Zlatina Stancheva, and Hideaki Miyoshi, and James W Perfield, and Jason DeFuria, and Zoe Jick, and Andrew S Greenberg, and Martin S Obin
December 2019, Genes & development,
Katherine J Strissel, and Zlatina Stancheva, and Hideaki Miyoshi, and James W Perfield, and Jason DeFuria, and Zoe Jick, and Andrew S Greenberg, and Martin S Obin
June 2011, The Journal of clinical investigation,
Katherine J Strissel, and Zlatina Stancheva, and Hideaki Miyoshi, and James W Perfield, and Jason DeFuria, and Zoe Jick, and Andrew S Greenberg, and Martin S Obin
April 2021, Cell reports,
Katherine J Strissel, and Zlatina Stancheva, and Hideaki Miyoshi, and James W Perfield, and Jason DeFuria, and Zoe Jick, and Andrew S Greenberg, and Martin S Obin
May 2018, Journal of lipid research,
Katherine J Strissel, and Zlatina Stancheva, and Hideaki Miyoshi, and James W Perfield, and Jason DeFuria, and Zoe Jick, and Andrew S Greenberg, and Martin S Obin
August 2021, eLife,
Katherine J Strissel, and Zlatina Stancheva, and Hideaki Miyoshi, and James W Perfield, and Jason DeFuria, and Zoe Jick, and Andrew S Greenberg, and Martin S Obin
June 2016, Diabetes,
Katherine J Strissel, and Zlatina Stancheva, and Hideaki Miyoshi, and James W Perfield, and Jason DeFuria, and Zoe Jick, and Andrew S Greenberg, and Martin S Obin
July 2010, Current opinion in clinical nutrition and metabolic care,
Katherine J Strissel, and Zlatina Stancheva, and Hideaki Miyoshi, and James W Perfield, and Jason DeFuria, and Zoe Jick, and Andrew S Greenberg, and Martin S Obin
July 2014, Cell metabolism,
Copied contents to your clipboard!